PD-L1 Checkpoint Blockade Promotes Regulatory T Cell Activity That Underlies Therapy Resistance

Researchers identified preferential activation and enhanced suppressive capacity of regulatory T cells in αPD-L1 therapy–resistant solid tumor–bearing mice.